Your browser doesn't support javascript.
A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study.
Munblit, Daniel; Nicholson, Timothy; Akrami, Athena; Apfelbacher, Christian; Chen, Jessica; De Groote, Wouter; Diaz, Janet V; Gorst, Sarah L; Harman, Nicola; Kokorina, Alisa; Olliaro, Piero; Parr, Callum; Preller, Jacobus; Schiess, Nicoline; Schmitt, Jochen; Seylanova, Nina; Simpson, Frances; Tong, Allison; Needham, Dale M; Williamson, Paula R.
  • Munblit D; Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child's Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia; Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College Lond
  • Nicholson T; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Akrami A; Sainsbury Wellcome Centre, UCL, London, UK; Patient-Led Research Collaborative, Otto von Guericke University Magdeburg, Magdeburg, Germany.
  • Apfelbacher C; Institute of Social Medicine and Health Systems Research, Faculty of Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany.
  • Chen J; Faculty of Medicine, Imperial College London, London, UK.
  • De Groote W; Department of Noncommunicable Diseases, Rehabilitation Programme, World Health Organization, Geneva, Switzerland.
  • Diaz JV; Clinical Management Team, World Health Organization, Geneva, Switzerland.
  • Gorst SL; Department of Health Data Science, University of Liverpool, Liverpool, UK.
  • Harman N; MRC/NIHR Trials Methodology Research Partnership, Department of Health Data Science, University of Liverpool, Liverpool, UK.
  • Kokorina A; Pirogov Russian National Research Medical University, Moscow, Russia.
  • Olliaro P; ISARIC Global Support Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Parr C; Faculty of Medicine, Imperial College London, London, UK.
  • Preller J; Health Care Readiness Unit, Health Emergencies Unit, World Health Organization, Geneva, Switzerland.
  • Schiess N; Brain Health Unit, World Health Organization, Geneva, Switzerland.
  • Schmitt J; Center for Evidence-based Healthcare, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Seylanova N; Moscow, Russia.
  • Simpson F; Coventry University, Coventry, UK.
  • Tong A; Sydney School of Public Health, The University of Sydney, Sydney, Australia.
  • Needham DM; Outcomes After Critical Illness and Surgery Research Group, Pulmonary and Critical Care Medicine, Department of Medicine, and Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Williamson PR; MRC/NIHR Trials Methodology Research Partnership, Department of Health Data Science, University of Liverpool, Liverpool, UK.
Lancet Respir Med ; 10(7): 715-724, 2022 07.
Article in English | MEDLINE | ID: covidwho-1886188
ABSTRACT
Health consequences that persist beyond the acute infection phase of COVID-19, termed post-COVID-19 condition (also commonly known as long COVID), vary widely and represent a growing global health challenge. Research on post-COVID-19 condition is expanding but, at present, no agreement exists on the health outcomes that should be measured in people living with the condition. To address this gap, we conducted an international consensus study, which included a comprehensive literature review and classification of outcomes for post-COVID-19 condition that informed a two-round online modified Delphi process followed by an online consensus meeting to finalise the core outcome set (COS). 1535 participants from 71 countries were involved, with 1148 individuals participating in both Delphi rounds. Eleven outcomes achieved consensus for inclusion in the final COS fatigue; pain; post-exertion symptoms; work or occupational and study changes; survival; and functioning, symptoms, and conditions for each of cardiovascular, respiratory, nervous system, cognitive, mental health, and physical outcomes. Recovery was included a priori because it was a relevant outcome that was part of a previously published COS on COVID-19. The next step in this COS development exercise will be to establish the instruments that are most appropriate to measure these core outcomes. This international consensus-based COS should provide a framework for standardised assessment of adults with post-COVID-19 condition, aimed at facilitating clinical care and research worldwide.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials / Reviews Topics: Long Covid Limits: Adult / Humans Language: English Journal: Lancet Respir Med Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Prognostic study / Randomized controlled trials / Reviews Topics: Long Covid Limits: Adult / Humans Language: English Journal: Lancet Respir Med Year: 2022 Document Type: Article